Welcome to our Annual Himss Orlando 2020 Survey

The cancellation of this year’s HIMSS 2020 – has left a hole for many vendors, as to how to reach out to their necessary market, and the reverse, how can hospitals and clinicians follow what is going on?

Every year we receive about one hundred or so requests for interviews and editorials, from PR companies and their healthcare clients. We take here what we feel are the most interesting of these and most relevant, and simply tell it like it is. We publish what they themselves have to say. And we invite you to make direct contact with the vendors concerned. Access to our report will cost you around $2.00, which goes towards our costs of putting the data together for you. And you can use our search bar on our site, to find any topic that might not be immediately visible that we might have spoken about here or earlier.

So.. here we go!

Is AI finally getting traction in Healthcare?

Ahead of Rare Disease Day (Feb 29), Ashley Yum has written to us,  to offer us the opportunity to speak with Steve Costalas, CEO, HVH Precision Analytics, about how AI and machine learning are being used to help diagnose rare diseases faster and more accurately.

HVH Precision Analytics is a joint venture between the world’s largest health and wellness network Havas Health & You , and Vencore,  and specializes in AI and machine learning data analytics.

At a time when take up of AI in healthcare is surprisingly low, this collaboration is looking at  how AI/big data can identify symptoms of disease 3-5 years before diagnosis, – and using RWD and RWE to find undiagnosed patients in healthcare databases – and finally, – · leveraging data to support the rare disease community beyond diagnosis.

And they have some interesting side announcements, if you will…

95% of rare diseases do not have an FDA-approved treatment, significantly limiting treatment options for the 400 million people living with a rare disease.

7,000 rare diseases have been identified, but only 5% have FDA-approved treatments.

The total number of Americans living with a rare disease is estimated at between 25-30 million.

The average time it takes for rare disease patients to receive an accurate diagnosis is 4.8 years.

However, they are  excited about the progress that’s been made in recent years thanks to AI, and  they would love to share  what they  think is in store for the future.

Ashley can be contacted at; ashley.yum@HVHprecision.com